KEGG pathway enrichment further indicated that multiple pathways including pathways in cancer, MAPK and PI3K-Akt signaling pathways could be associated with the inhibitory effects of FMNT and CS against colon cancer (Figure 4). The gene discussed is AKT1; the disease is malignant colon neoplasm.